Influence of On-Pump Versus Off-Pump Techniques and Completeness of Revascularization on Long-Term Survival After Coronary Artery Bypass

2008 ◽  
Vol 86 (3) ◽  
pp. 797-805 ◽  
Author(s):  
Omar M. Lattouf ◽  
Vinod H. Thourani ◽  
Patrick D. Kilgo ◽  
Michael E. Halkos ◽  
Kim T. Baio ◽  
...  
2013 ◽  
Vol 95 (6) ◽  
pp. 1952-1960 ◽  
Author(s):  
Faisal G. Bakaeen ◽  
Danny Chu ◽  
Rosemary F. Kelly ◽  
Herbert B. Ward ◽  
Michael E. Jessen ◽  
...  

2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
F A Saraiva ◽  
R J Cerqueira ◽  
A F Ferreira ◽  
R Moreira ◽  
M J Amorim ◽  
...  

Abstract Background The role and the indications for using off-pump coronary artery bypass surgery (OPCAB), instead of the traditional on-pump (ONCAB), is still to be addressed. Aim To describe our centre experience and to compare 15-years survival and early safety outcomes between OPCAB and ONCAB. Methods Single-centre retrospective cohort including 9-years of isolated first CABG (2005–2013). Multi-vessel disease with at least 2 surgical grafts patients were considered and the first 50 surgeries of each surgeon with each technique were excluded to account for the learning curve effect. Emergent surgeries and on-pump beating heart procedures were also excluded. A propensity-score matching (PSM) analysis was performed to balance groups and both survival and early outcomes comparison was done within the matched cohort using Kaplan-Meier or Cox stratified and paired tests, respectively. The median follow-up was 9 years, maximum 15 years. Results From 3012 multi-vessel patients with at least 2 surgical grafts, 2503 were included at the main analysis: 1487 ONCAB and 1016 OPCAB. ONCAB patients presented more frequently 3-vessels disease and left ventricular dysfunction, but received similar number of grafts than OPCAB, who in turn, received more frequently multiple arterial grafts. The surgical completeness of revascularization (CR) was similar, but hybrid procedures were more frequent in OPCAB raising CR rate in this group. After PSM (646 pairs), both groups were similar regarding pre and peri-operative characteristics. The long-term survival was similar (HR stratified by pair: 1.02 (0.81–1.30), but OPCAB evidenced benefits at early term results including bleeding, postoperative atrial fibrillation and stroke incidence. Conclusion At our centre, OPCAB performed by experienced surgeons provides rates of complete revascularization and long-term survival similar to ONCAB. In-hospital results favoured OPCAB. FUNDunding Acknowledgement Type of funding sources: Other. Main funding source(s): Universidade do Porto/FMUP; Social European Fund; FCT-Fundação para a Ciência e a Tecnologia


2020 ◽  
Vol 9 (5) ◽  
pp. 1345
Author(s):  
Mariusz Kowalewski ◽  
Marek Jasiński ◽  
Jakub Staromłyński ◽  
Marian Zembala ◽  
Kazimierz Widenka ◽  
...  

The current investigation aimed to evaluate long-term survival in patients undergoing isolated and combined coronary artery bypass grafting (CABG) with concomitant surgical ablation for atrial fibrillation (AF). Procedural data from KROK (Polish National Registry of Cardiac Surgery Procedures) were retrospectively collected. Eleven thousand three hundred sixteen patients with baseline AF (72.4% men, mean age 69.6 ± 7.9) undergoing isolated and combined CABG surgery between 2006–2019 in 37 reference centers across Poland and included in the registry were analyzed. The median follow-up was four years (3.7 IQR 1.3–6.8). Over a 12-year study period, there was a significant survival benefit (Hazard Ratio (HR) 0.83; (95% Confidence Interval (CI): 0.73–0.95); p = 0.005) with concomitant ablation as compared to no concomitant ablation. After rigorous propensity matching (LOGIT model, 432 pairs), concomitant surgical ablation was associated with over 25% improved survival in the overall analysis: HR 0.74; (95% CIs: 0.56–0.98); p = 0.036. The benefit of concomitant ablation was maintained in the subgroups, yet the most benefit was appraised in low-risk patients (EuroSCORE < 2, p = 0.003) with the three-vessel disease (p < 0.001) and without other comorbidities. Ablation was further associated with significantly improved survival in patients undergoing CABG with mitral valve surgery (HR 0.62; (95% CIs: 0.52–0.74); p < 0.001) and in patients in whom complete revascularization was not achieved: HR 0.43; (95% CIs: 0.24–0.79); p = 0.006.


2017 ◽  
Vol 26 (2) ◽  
pp. 257-263 ◽  
Author(s):  
Md N Karim ◽  
Christopher M Reid ◽  
Molla Huq ◽  
Samuel L Brilleman ◽  
Andrew Cochrane ◽  
...  

2006 ◽  
Vol 81 (5) ◽  
pp. 1650-1657 ◽  
Author(s):  
Colleen Gorman Koch ◽  
Liang Li ◽  
Andra I. Duncan ◽  
Tomislav Mihaljevic ◽  
Floyd D. Loop ◽  
...  

2012 ◽  
Vol 42 (1) ◽  
pp. 101-107 ◽  
Author(s):  
F. O'Boyle ◽  
N. Mediratta ◽  
B. Fabri ◽  
M. Pullan ◽  
J. Chalmers ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document